Kamal has more than 40 years of teaching and research experience at major US academic institutions. Dr. Rashid’s is widely published in the field of cell culture and upstream bioprocesses. He has been invited to speak at conferences around the world and has received numerous research and workforce development grants, including a U.S. Biomedical Advanced Research and Development Authority (BARDA) grant for vaccine manufacturing training delivered in 13 countries. As a consultant, Dr. Rashid has worked globally with several public and private companies, academic institutions and governments, leading teams to develop and deliver biomanufacturing and vaccine manufacturing training programs.
China is investing heavily in R&D and they know this is the first step to achievement in this industry. Investment in the workforce is also essential. To produce a good product that will receive approval, you need both manpower and facilities. There is a need for a good workforce to make innovation a reality. This is something China is getting into more aggressively.17 February 2021